XML 68 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue - Manufacturing Service Agreements (Details) - USD ($)
$ in Thousands
 7 Months Ended 12 Months Ended
Jul. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Jun. 30, 2023
Jan. 31, 2022
Collaboration and Other Agreements [Line Items]            
Revenues   $ 58,749 $ 151,941 $ 77,447    
Incyte Corporation (Incyte) | RevenuesFromCMOAgreementsMember            
Collaboration and Other Agreements [Line Items]            
Non-refundable upfront payment $ 10,000          
Total annual fixed payments   14,400        
Revenues   9,700 8,700      
Deferred revenue   7,000 9,600      
Deferred revenue, current     8,100      
Deferred revenue, noncurrent     $ 1,500      
Incyte Corporation (Incyte) | RevenuesFromCMOAmendmentAgreement            
Collaboration and Other Agreements [Line Items]            
Total annual fixed payments         $ 19,500  
Additional annual fixed payments   5,100        
Incyte Corporation (Incyte) | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement            
Collaboration and Other Agreements [Line Items]            
Collaborative arrangement, term           3 years
Collaborative arrangement, extension term           1 year
Provention Bio, Inc. (Provention) | Provention Bio CMO Agreeemnt            
Collaboration and Other Agreements [Line Items]            
Revenues   5,300        
upfront and fixed payments   $ 4,600